NovoCure Ltd. (NVCR) PT Raised to $99 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Price: $13.11 -7.48%
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 20 | New: 0
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 20 | New: 0
Join SI Premium – FREE
JPMorgan analyst Jessica Fye raised the price target on NovoCure Ltd. (NASDAQ: NVCR) to $99.00 (from $86.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Novocure (NVCR) Tops Q3 EPS by 14c; Offers Guidance
- Coursera Inc (COUR) PT Lowered to $6 at Needham
- Novocure and Verastem to trial TTFields with KRAS inhibitor in pancreatic cancer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
